← Ambroxol hydrochloride + Terbutaline sulphate + Guaiphenesin)

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Ambroxol hydrochloride + Terbutaline sulphate + Guaiphenesin)

Beta-2 adrenergic agonist (bronchodilator)

Prepared 25 Sep 2026

What it is used for

Relief of cough associated with bronchitis, bronchial asthma, emphysema and other bronchopulmonary disorders where bronchospasm, mucous plugging, and problems of expectoration co-exist. Clinical selection for Ambroxol hydrochloride + Terbutaline sulphate + Guaiphenesin) should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Beta-2 adrenergic agonist (bronchodilator). Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Paradoxical bronchospasm. Hypokalaemia with high dose/nebs especially with steroids/diuretics/xanthines. CV disease: tachycardia/arrhythmia risk. Thyrotoxicosis caution.

Possible side effects

[From component Terbutaline sulphate] Tachycardia, skeletal muscle cramp, palpitation, headaches, severe emotional disturbances, resistance after prolonged use, acidosis, GI disturbances, hypokaleamia, sweat

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage